 |
 |
 |
 |
"Functional HepaRG Cells: A breakthrough breakthrough in 3-R research?"
André Guillouzo
University University of Rennes 1and Inserm U620
|
 |
 |
 |
 |
 |
"Hepatocyte in vitro gene expression systems: what is the reason for differences between in vivo and and in vitro systems?"
Markus Schug, Dipl. Pharm.
Leibniz Research Centre for Working Environment and Human Factors (IfADo)
|
 |
 |
 |
 |
 |
"Non-genotoxic hepatocarcinogens specifically target mitochondria and gap junctions"
Tatyana Doktorova PhD student
Vrije Universiteit Brussel
Promotors: Prof. Dr. Vera Rogiers, Prof. Dr. Tamara Vanhaecke, Dr. Mathieu Vinken
|
 |
 |
 |
 |
 |
"Cytotoxic and genotoxic effects of two heterocyclic amines in functional human hepatoma HepaRG cells"
Julie Dumont 1, Rozenn Jossé 1, Valérie Fessard 2, André Guillouzo 1
1 - Inserm U620 , Rennes 1 University, Rennes, France 2 - AFSSA, Unit of genetic toxicology of food contaminants, Fougères, France
|
 |
 |
 |
 |
 |
"Markers of proliferation and differentiation in human keratinocyte models"
Yves Poumay
Cell & Tissue Laboratory - URPHYM
University of Namur (Facultés Universitaires Notre-Dame de la Paix) Namur, Belgium
|
 |
 |
 |
 |
 |
"MicroRNAs: novel regulators in skin research"
Eniko Sonkoly, Andor Pivarcsi
KI, Department of Medicine, Unit of Dermatology and Venerology
|
 |
 |
 |
 |
 |
"Use of gene silencing in skin models"
Michael Mildner
|
 |
 |
 |
 |
 |
"Safety aspects of skin penetration of nanoparticles in topically applied cosmetics / pharmaceuticals"
A. Patzelt, H. Richter, W. Sterry, J. Lademann
Center of Experimental and Applied Cutaneous Physiology (CCP)
|
 |
 |
 |
 |
 |
"Nanoparticle induced pulmonary toxicity"
N.J. Guppy, Institute of Cellular and Molecular Science, QMUL, London, UK
Experimental Toxicology and Ecology, BASF SE, Ludwigshafen, Germany
|
 |
 |
 |
 |
 |
"Toxicological Studies Of Poly (Anyhydride) Nanoparticles For Oral Drug Delivery"
Patricia Ojer Ojer, Dr. Juan Manuel Irache1, Dra. Adela López de Cerain2
Department of Pharmacy and Pharmaceutical Technology1 & Department of Nutrition and Food Sciences, Physiology and Toxicology2 University of Navarra
|
 |
 |
 |
 |
 |
"Important issues in immunotoxicity testing of chemicals"
Pr Marc Pallardy
Toxicologie and INSERM UMR-S 749, Faculté de Pharmacie, Châtenay-Malabry, France
|
 |
 |
 |
 |
 |
"Development Of Iv Vitro Strategies For Studying T-Cell Mediated To Immunological Reactions To Drugs "
Enrique Gomez
Research Laboratory Fundacion IMABIS-Carlos Haya Hospital Málaga, Spain
|
 |
 |
 |
 |
 |
"In-vitro quantitation of sensitizing potential"
Reinhard Wanner
Institute of Clinical Pharmacology and Toxicology Charité, Berlin, Germany
|
 |
 |
 |
 |
 |
"Reactivity studies to complement the development of alternative methods for the prediction of skin sensitization: the case of formaldehyde and formaldehyde releasers"
M. Kireche, E. Giménez-Arnau, J.P. Lepoittevin
Institut de Chimie de Strasbourg UniversitéLouisPasteur-CNRS Université Louis Pasteur-CNRS Laboratoire de Dermatochimie Strasbourg, France
|
 |
 |
 |
 |
 |
"In vitro differentiation of skin sensitizers by cell signaling pathways"
Lydia-Mareen Koeper,
Bayer HealthCare AG, Toxicology
|
 |
 |
 |
 |
 |
"Identification of cell responses induced by a sensitizer in a"
Aurélie Frankart, S. Lambert, A. Coquette, K. Schroeder and Prof. Yves Poumay
|
 |
 |
 |
 |
 |
"About Pipelines and Shifting paradigms: biopharmaceuticals versus low molecular weight drugs"
Prof. Dr. Daan, J.A. Crommelin,
Scientific Director TI Pharma, a Public Private Partnership, Leiden and Dept. Pharmaceutics, UIPS, UU
|
 |
 |
 |
 |
 |
 |
"Prednisolone-treatment induces hepatic insulin resistance in C57Bl/6J mice, measured by a newly develobody glucose test"
Anke Laskewitz
Lab pediatrics Center for liver, digestive and metabolic diseases University medical center Groningen The Netherlands
|
 |
 |
 |
 |
 |
"A suitable delivery system is key in the concept of siRNA-mediated treatment"
R. Vandenbroucke
Laboratory of General Biochemistry and Physical Pharmacy
Ghent Research Group on Nanomedicines (GRGN)
Department of Pharmaceutics Ghent University, Belgium
|
 |
 |
 |
 |
 |
"Molecular imaging in vitro and in vivo"
Tony Lahoutte, MD PhD
Free University Brussels
|
 |
 |
 |
 |
 |
"An alternative method in (live) cell sampling"
Renate Burgemeister
Laser Microdissection from Carl Zeiss
|
 |
 |
 |
 |
 |
"COMICS: developing high throughput comet assays for DNA damage and DNA repair"
Amaya Azqueta
on behalf of COMICS partners Department of Nutrition University of Oslo
|
 |
 |
 |
 |
 |
"Use of flow-based assays to monitor drugs with antithrombotic, anticoagulant or anti-inflammatory potential"
J. Heemskerk, J. Cosemans
Dept. of Biochemistry Cardiovascular Research Institute Maastricht (CARIM) Maastricht University Medical Centre+, The Netherlands
|
 |
 |
 |
 |
 |
"Confrontation cultures of embryonic stem cell-derived embryoid bodies and multicellular tumour spheroids: a novel in vitro model for the study of tumour- induced angiogenesis"
N. Milosevic1, Finkensieper2, M. Hannig2, M. Wartenberg2, H. Sauer1
1 Department of Physiology, University of Giessen, Germany
2 Department of Internal Medicine I, University of Jena,Germany
|
 |
 |
 |
 |
 |
"Organotypic in vitro skin cancer model"
Suzan Commandeur, MSc
Department of Dermatology, Leids Universitair Medisch Centrum
|
 |
 |
 |
 |
 |
"Evaluation of toxicological effects of POPs using primary fish cell cultures"
Liv Søfteland, Invar Eide and Pål A. Olsvik
National Institute of Nutrition and Seafood Research
|
 |
 |
 |
 |
 |
"Free Concentrations in In Vitro Cytotoxicity Assays"
Nynke Kramer, Bas Blaauboer and Joop Hermens
Institute for Risk Assessment Sciences, Division Toxicology, Universiteit Utrecht
|
 |
 |
 |
 |
 |
"A Cell-Basec Assay For The Detection Of A Potent Algal Neurotoxin In Biological Matrices"
Mirella Bellocci
Università di Modena e Reggio Emilia, Modena, Italy
|
 |
 |
 |
 |
 |
"Regulatory Acceptance and Use of in vitro Methods for Non-Clinical Testing of Human Medicinal Products"
Dr. Sonja Beken
Non-Clinical Assessor, Registration Department
Federal Agency for Medicines and Health Products (FAMHP)
|
 |
 |
 |
 |
 |
"Validation and Regulatory Acceptance"
Susanne N. Boehn
Laboratory for Alternative Methods Experimental Toxicology and Ecology, BASF SE, Ludwigshafen, Germany
|
 |
 |